Electrophysiology
AF management, anticoagulation, and rhythm control
Emerging evidence with 100 primary claims
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does vitamin k antagonist vs placebo improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitvitamin k antagonist vs placebo · Cardiac Index
Does anticoagulants vs placebo improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitanticoagulants vs placebo · Stroke Hospitalization
Does warfarin vs placebo improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitwarfarin vs placebo · Acute Kidney Injury
Does rivaroxaban vs warfarin improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitrivaroxaban vs warfarin · Stroke Hospitalization
Does edoxaban vs warfarin improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitedoxaban vs warfarin · Stroke Hospitalization
Does dabigatran vs warfarin improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitdabigatran vs warfarin · Stroke Hospitalization
Does apixaban vs warfarin improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitapixaban vs warfarin · Stroke Hospitalization
Does semaglutide vs placebo improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitsemaglutide vs placebo · Urinary Tract Infection
Does rivaroxaban vs warfarin improve Ventricular Arrhythmia in Nonvalvular atrial fibrillation?
Low Certainty+ Favors benefitrivaroxaban vs warfarin · Ventricular Arrhythmia
Does warfarin vs placebo improve Major Bleeding in Atrial Fibrillation?
Low Certainty+ Favors benefitwarfarin vs placebo · Major Bleeding
Does aspirin vs warfarin improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitaspirin vs warfarin · Stroke Hospitalization
Does apixaban vs warfarin improve Stroke Hospitalization in Atrial Fibrillation?
Low Certainty+ Favors benefitapixaban vs warfarin · Stroke Hospitalization
Questions where the synthesized consensus has shifted as new trials were indexed.
Does vitamin k antagonist vs placebo improve outcomes in Atrial Fibrillation?
Low Certainty+ Favors benefitvitamin k antagonist vs placebo · Cardiac Index
Does rivaroxaban vs dabigatran improve outcomes in Atrial Fibrillation?
Low Certainty− Favors harmrivaroxaban vs dabigatran · Stroke Hospitalization
Atrial fibrillation (also known as AF, AFib, A-fib). AF management, anticoagulation, and rhythm control
Synapse tracks 23 specific clinical questions in Atrial fibrillation, each synthesized independently from its own trial evidence. They include: "Does vitamin k antagonist vs placebo improve outcomes in Atrial Fibrillation?"; "Does anticoagulants vs placebo improve outcomes in Atrial Fibrillation?"; "Does warfarin vs placebo improve outcomes in Atrial Fibrillation?"; "Does rivaroxaban vs warfarin improve outcomes in Atrial Fibrillation?"; "Does edoxaban vs warfarin improve outcomes in Atrial Fibrillation?".
As of 2026-06-25, the scientific consensus on Atrial fibrillation is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/69b0a308b42209bc31dca335.
Deterministic synthesis from Synapse's enriched corpus — 120 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Atrial fibrillation paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Atrial fibrillation papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers